On June 4, 2024, the Lok Sabha election results defied expectations. Exit polls had predicted that the National Democratic Alliance (NDA) would secure between 350 to 400 seats. Based on these projections, the equity market surged around 2% as Foreign Institutional Investors (FIIs) turned net buyers on that day. However, the actual results revealed that
Company Profile This company is a leading manufacturer of high-purity specialty fine chemicals. Their products are utilized across a diverse array of end-user industries. These chemicals play critical roles in various applications, including: Pharmaceuticals: As key reacting agents and raw materials for Active Pharmaceutical Ingredients (APIs), and as excipients within pharmaceutical formulations. Research & Development:
Incorporated in 2008, P.E. Analytics, also known as PropEquity, offers a proprietary Real Estate Business Intelligence and Analytics platform on a B2B model. Serving developers, the construction industry, investors, banks, housing finance companies, equity research firms, financial institutions, and mortgage insurers, the company delivers reliable real estate data, analytics, and market research reports. These services
Incorporated in December 2016, We are one of the leading digital full stack insurance companies, leveraging our technology to power what we believe to be an innovative approach to product design, distribution, and customer experience for non-life insurance products. Digital full stack insurance companies are licensed insurance operators or companies that have end-to-end digital capabilities
Company is in the business of designing, manufacturing, branding and selling of ready-made apparels in the men’s segment and other accessories under various brands. Company brands range from the high fashion premium segment such as ‘Killer’ for denim wear and ‘Easies’ for casual wear to the middle and economy segments through brands such as ‘Lawman’
About the Company When we read about the promoter’s background then we found that promoter Mr. Mark Saldanha is a part of the family owing Glenmark Pharmaceuticals group. Glenmark was established by his father Gracias Saldanha. Mr Gracias Saldanha named the company Glenmark after the names of his two sons, Glenn Saldanha and Mark Saldanha